Your browser doesn't support javascript.
loading
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report.
Del Re, Marzia; Rofi, Eleonora; Cappelli, Carla; Puppo, Gianfranco; Crucitta, Stefania; Valeggi, Simona; Chella, Antonio; Danesi, Romano; Petrini, Iacopo.
Afiliação
  • Del Re M; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 55, Via Roma, 56126, Pisa, Italy.
  • Rofi E; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 55, Via Roma, 56126, Pisa, Italy.
  • Cappelli C; Unit of Diagnostic and Interventional Radiology, Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, Pisa, Italy.
  • Puppo G; Unit of Respiratory Medicine, Department of Critical Area and Surgical, Medical and Molecular Pathology, University Hospital of Pisa, Pisa, Italy.
  • Crucitta S; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 55, Via Roma, 56126, Pisa, Italy.
  • Valeggi S; Unit of Respiratory Medicine, Department of Critical Area and Surgical, Medical and Molecular Pathology, University Hospital of Pisa, Pisa, Italy.
  • Chella A; Unit of Respiratory Medicine, Department of Critical Area and Surgical, Medical and Molecular Pathology, University Hospital of Pisa, Pisa, Italy.
  • Danesi R; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, 55, Via Roma, 56126, Pisa, Italy. romano.danesi@unipi.it.
  • Petrini I; Unit of Respiratory Medicine, Department of Critical Area and Surgical, Medical and Molecular Pathology, University Hospital of Pisa, Pisa, Italy.
BMC Cancer ; 19(1): 410, 2019 Apr 30.
Article em En | MEDLINE | ID: mdl-31039766

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acrilamidas / Deleção de Sequência / Carcinoma Pulmonar de Células não Pequenas / Compostos de Anilina / Neoplasias Pulmonares Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acrilamidas / Deleção de Sequência / Carcinoma Pulmonar de Células não Pequenas / Compostos de Anilina / Neoplasias Pulmonares Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article